MktsMarkets

BioCryst Pharmaceuticals, Inc.
NASDAQ: BCRXKey statistics
BCRX News
Stories mentioning BCRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 5,377 | 9,522 | 2,187 | 2,798 | 4,568 | 6,094 | 3,211 | 1,699 |
| Gross Profit | (5,377) | (9,522) | (2,187) | (2,798) | (4,568) | (6,094) | (3,211) | (1,699) |
| Operating Expenses | ||||||||
| Research & Development | 60,319 | 40,867 | 44,603 | 43,386 | 37,270 | 49,441 | 41,081 | 37,623 |
| Sales General & Admin | 94,554 | 95,781 | 83,014 | 87,383 | 82,469 | 80,507 | 65,101 | 61,249 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (701,598) | 260,385 | 29,591 | 29,786 | 21,227 | (4,508) | 7,692 | 8,761 |
| Interest Income | ||||||||
| Interest Expense | 24,733 | |||||||
| Other Expense | (1,462) | 0.00 | ||||||
| Pretax Income | (720,808) | 248,017 | 12,130 | 6,486 | 758.00 | (25,991) | (13,447) | (12,502) |
| Tax Provision | 1,004 | 2,172 | (769.00) | 1,401 | 726.00 | 804.00 | 586.00 | 172.00 |
| Net Income (Loss) | (721,812) | 245,845 | 12,899 | 5,085 | 32.00 | (26,795) | (14,033) | (12,674) |
| Earnings Per Share (Basic) | (2.98) | 1.17 | 0.06 | 0.02 | 0.00 | (0.13) | (0.07) | (0.06) |
| Earnings Per Share (Diluted) | (2.98) | 1.12 | 0.06 | 0.02 | 0.00 | (0.13) | (0.07) | (0.06) |
| Weighted Average Shares Outstanding (Basic) | 242,258 | 209,893 | 210,176 | 209,519 | 208,882 | 206,696 | 206,905 | 206,425 |
| Weighted Average Shares Outstanding (Diluted) | 242,258 | 218,581 | 219,885 | 219,886 | 215,261 | 206,696 | 206,905 | 206,425 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BCRX
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCRX. It last traded at $7.69 (Nov 6, 2026, 4:00 PM ET), up 0.8% on the day. That gives BioCryst Pharmaceuticals a market capitalisation of $2.0B.
Over the past 52 weeks BCRX has traded between $6.23 and $11.22.
For the quarter ended Mar 31, 2026 it reported a net loss of $721.8M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$721.8M |
| Dec 31, 2025 | — | $245.8M |
| Sep 30, 2025 | — | $12.9M |
| Jun 30, 2025 | — | $5.1M |
From BioCryst Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…